What's Driving Price Increases For Addiction Treatment Drugs?

At House hearing, PhRMA representative cites introduction of innovative delivery systems while GPhA exec points to manufacturing costs; state attorneys general file Suboxone 'product hopping' suit.

The brand name and generic drug industries once again came under congressional fire for increases in drug pricing, this time for medicines to treat opioid addiction and overdose.

The House Judiciary's Subcommittee on Regulatory Reform, Commercial and Antitrust Law held a Sept. 22 hearing on the state of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access